LSL Pharma Group Expands with Virage Santé Buyout

LSL Pharma Group Inc (TSE:LSL) has released an update.

LSL Pharma Group Inc. has successfully acquired Virage Santé, a manufacturer and marketer of natural health products, enhancing the company’s contract development and manufacturing capabilities. The $2.5 million cash purchase includes an 8,000 sq ft manufacturing plant and is expected to increase LSL Pharma’s revenues by 15-20% and expand its customer base. The acquisition aligns with LSL Pharma’s growth strategy to diversify services and strengthen its position in the pharmaceutical sector.

For further insights into TSE:LSL stock, check out TipRanks’ Stock Analysis page.